✦ LIBER ✦

Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab

✍ Scribed by Bakall, Benjamin; Folk, James C.; Boldt, H. Culver; Sohn, Elliott H.; Stone, Edwin M.; Russell, Stephen R.; Mahajan, Vinit B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ranibizumab and Bevacizumab for Neovascu

📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 679 KB

Intravitreal Aflibercept for Treatment-R

✍ Chang, Andrew A.; Li, Haitao; Broadhead, Geoffrey K.; Hong, Thomas; Schlub, Timo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Intravitreal bevacizumab for exudative a

✍ Fabio Bom Aggio; Michel Eid Farah; Wagner Camilo Silva; Gustavo Barreto Melo 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 348 KB

Microperimetric changes after intravitre

✍ Florian Rensch; Jost B. Jonas 📂 Article 📅 2008 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 277 KB

Retinal Pigment Epithelium Tears Followi

✍ Petros E. Carvounis; Andrew C. Kopel; Matthew S. Benz 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Ranibizumab Combined With Low-Dose Soraf

✍ Diago, Teresa; Pulido, Jose S.; Molina, Julian R.; Collet, Lucienne C.; Link, Th 📂 Article 📅 2008 🏛 Mayo Clinic 🌐 English ⚖ 150 KB